The Chemours Company (NYSE:CC – Get Free Report) declared a quarterly dividend on Tuesday, February 17th. Stockholders of record on Friday, February 27th will be given a dividend of 0.0875 per share by the specialty chemicals company on Friday, March 13th. This represents a c) dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date is Friday, February 27th.
Chemours has a dividend payout ratio of 14.5% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Chemours to earn $2.71 per share next year, which means the company should continue to be able to cover its $0.35 annual dividend with an expected future payout ratio of 12.9%.
Chemours Price Performance
Shares of CC stock opened at $21.18 on Thursday. The business’s fifty day moving average is $15.01 and its 200 day moving average is $14.36. The company has a quick ratio of 0.88, a current ratio of 1.71 and a debt-to-equity ratio of 13.66. The stock has a market cap of $3.17 billion, a price-to-earnings ratio of -9.54 and a beta of 1.63. Chemours has a twelve month low of $9.13 and a twelve month high of $21.85.
Institutional Inflows and Outflows
About Chemours
Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.
Chemours’ principal business activities are organized into three core segments.
Featured Articles
- Five stocks we like better than Chemours
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- New gold price target
Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.
